Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
With
National Heart, Lung, and Blood Institute (NHLBI)
Age
25–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥5% non-surgical weight loss from NYULH-WMP and NY-MOVE! Endocrinology Weight Management Clinic in the last 3 months
BMI between 20.5 - 45 m/kg2
between the ages 25 to 65 years old
own a smartphone or willing to use a smartphone if provided for self-monitoring
Eating window \>12 h per day
\<150 mins/wk of physical activity
log at least 2 meals into the smartphone app on ≥5 days
You may not be if
\<25 years or \>65 years of age
Body weight in excess of 400lbs (181.4kg)
pregnant, trying to get pregnant or breastfeeding
previous or planned bariatric surgery
previous or current history of eating disorder
ongoing participation in another weight-management research study
continued participation in a weight loss program other than the proposed study
currently on appetite suppressants
currently following intermittent fasting or skipping meals
eating window \<11h 59min/day
perform overnight shift work more than once a week
work that includes travel across one or more time zones
currently on anti-obesity medications (AOMs) such as, GLP-1 analogues (exenatide, tirzepatide, semaglutide, liraglutide) and pancreatic lipase inhibitors (Orlistat/Xenical and Alli)
prescribed medications expected to result in weight loss such as Orlistat, Naltrexone, Bupropion, Lorcaserin, Phentermine, Topiramate, or Liraglutide, and who are unwilling to delay treatment with these medications for the next 3 months
unable or unwilling to provide informed consent
unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment)
unwilling to accept randomization assignment
unable to log at least 2 meals into the smartphone app on ≥5 d during the screening period
have type 1 or other conditions that would preclude restricted eating windows
have type 2 diabetes with a HbA1c \>7.0% on medications except for metformin alone
narcolepsy
active cancer
organ dysfunction
current steroid use
daytime sleepiness with the Epworth Sleepiness Scale \>10
severe insomnia with a score ≥15 on the Insomnia Severity Index
Clareo Health | Time Restricted Eating for Weight Loss Maintenance
